Development and validation of a LC-MS/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood-brain barrier models

被引:8
|
作者
Jaehne, Evelyn A. [1 ]
Eigenmann, Daniela E. [1 ]
Culot, Maxime [2 ]
Cecchelli, Romeo [2 ]
Walter, Fruzsina R. [3 ]
Deli, Maria A. [3 ]
Tremmel, Robin [4 ]
Fricker, Gert [4 ]
Smiesko, Martin [5 ]
Hamburger, Matthias [1 ]
Oufir, Mouhssin [1 ]
机构
[1] Univ Basel, Dept Pharmaceut Sci, Inst Pharmaceut Biol, CH-4056 Basel, Switzerland
[2] Univ Lille Nord France, UArtois, BBB Lab EA 2465, IMPRT IFR114, F-62307 Lens, France
[3] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6726 Szeged, Hungary
[4] Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
[5] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Isatis tinctoria; (E,Z)-3-(4-Hydroxy-3,5-dimethoxybenzylidene)indolin-2-one; Anti-inflammatory; LC-MS/MS; Blood-brain barrier (BBB); TINCTORIA LEAF EXTRACTS; P-GLYCOPROTEIN EFFLUX; ISATIS-TINCTORIA; ENDOTHELIAL-CELLS; INHIBITORY-ACTIVITY; KINASE INHIBITORS; PURE TRYPTANTHRIN; DRUG DISCOVERY; PERMEABILITY; SYSTEM;
D O I
10.1016/j.jpba.2014.05.026
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The compound (E,Z)-3-(4-hydroxy-3,5-dimethoxybenzylidene)indolin-2-one (indolinone) was identified from lipophilic woad extracts (Isatis tinctoria L, Brassicaceae) as a compound possessing potent histamine release inhibitory and anti-inflammatory properties [1]. To further evaluate the potential of indolinone in terms of crossing the blood-brain barrier (BBB), we screened the compound in several in vitro cell-based human and animal BBB models. Therefore, we developed a quantitative LC-MS/MS method for the compound in modified Ringer HEPES buffer (RHB) and validated it according to FDA and EMA guidelines [2,3]. The calibration curve of indolinone in the range between 30.0 and 3000 ng/ml was quadratic, and the limit of quantification was 30.0 ng/ml. Dilution of samples up to 100-fold did not affect precision and accuracy. The carry-over was within acceptance criteria. Indolinone proved to be stable in RHB for 3 h at room temperature (RT), and for three successive freeze/thaw cycles. The processed samples could be stored in the autosampler at 10 degrees C for at least 28 h. Moreover, indolinone was stable for at least 16 days in RHB when stored below -65 degrees C. This validation study demonstrates that our method is specific, selective, precise, accurate, and capable to produce reliable results. In the immortalized human BBB mono-culture model, the apparent permeability coefficient from apical to basolateral (P-app A -> B), and the P-app from basolateral to apical (P-app (B -> A)) were 19.2 +/- 0.485 x 10(-6) cm/s and 21.7 +/- 0.326 x 10-6 cm/s, respectively. For the primary rat/bovine BBB co-culture model a P-app (A -> B) Of 27.1 +/- 1.67 x 10(-6) cm/s was determined. In the primary rat BBB triple co-culture model, the P-app A -> B and the P-app (B -> A) were 56.2 +/- 3.63 x 10(-6) cm/s and 34.6 +/- 1.41 x 10(-6) cm/s, respectively. The data obtained with the different models showed good correlation and were indicative of a high BBB permeation potential of indolinone confirmed by in silica prediction calculations. P-glycoprotein (P-gp) interaction for indolinone was studied with the aid of a calcein-AM uptake assay, and by calculation of the efflux ratio (ER) from the bidirectional permeability assays. For both bidirectional BBB models an ER below 2 was calculated, indicating that no active mediated transport mechanism is involved for indolinone. In porcine brain capillary endothelial cells (PBCECs), the calcein-AM uptake assay demonstrated that indolinone is neither a P-gp substrate nor a P-gp inhibitor and is accumulated into cells at high extent. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 50 条
  • [41] Development and clinical validation of an LC-MS/MS method for the quantification of pazopanib in DBS
    Verheijen, Remy B.
    Bins, Sander
    Thijssen, Bas
    Rosing, Hilde
    Nan, Lianda
    Schellens, Jan H. M.
    Mathijssen, Ron H. J.
    Lolkema, Martijn P.
    Beijnen, Jos H.
    Steeghs, Neeltje
    Huitema, Alwin D. R.
    BIOANALYSIS, 2016, 8 (02) : 123 - 134
  • [42] Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma
    Challenger, Elizabeth
    Penchala, Sujan Dilly
    Hale, Colin
    Fitzgerald, Richard
    Walker, Lauren
    Reynolds, Helen
    Chiong, Justin
    Fletcher, Tom
    Khoo, Saye
    Else, Laura
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 233
  • [43] An LC-MS/MS Method Development and Validation for the Quantification of Abametapir in Plasma Samples
    Sankar, Palakollu D. S.
    Panigrahi, Naresh
    SEPARATION SCIENCE PLUS, 2025, 8 (01):
  • [44] Development and validation of a LC-MS/MS method for quantification of hetrombopag for pharmacokinetics study
    Chen, Tao
    Chen, Zhonghua
    Zhang, Suxing
    Zhang, Kezhi
    Wang, Laiyou
    SPRINGERPLUS, 2015, 4
  • [45] LC-MS Method for the Simultaneous Quantitation of the Anti-inflammatory Constituents in Oregano (Origanum Species)
    Shen, Diandian
    Pan, Min-Hsiung
    Wu, Qing-Li
    Park, Chung-Heon
    Juliani, H. Rodolfo
    Ho, Chi-Tang
    Simon, James E.
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2010, 58 (12) : 7119 - 7125
  • [46] Development and validation of LC-MS/MS method for the determination of UV-filters across human skin in vitro
    Pafili, Anastasia
    Meikopoulos, Thomas
    Kontogiannidou, Eleni
    Papageorgiou, Spyros
    Demiri, Efterpi
    Meimari, Despoina
    Fatouros, Dimitrios G.
    Gika, Helen
    Theodoridis, Georgios
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2021, 1167
  • [47] Development of a rapid LC-MS/MS method for ribavirin determination in rat brain
    Zironi, Elisa
    Gazzotti, Teresa
    Lugoboni, Barbara
    Barbarossa, Andrea
    Scagliarini, Alessandra
    Pagliuca, Giampiero
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 54 (04) : 889 - 892
  • [48] LC-MS/MS analysis and evaluation of the anti-inflammatory activity of components from BushenHuoxue decoction
    Sun, Dongdong
    Yan, Qiuying
    Xu, Xiaofang
    Shen, Weixing
    Xu, Changliang
    Tan, Jiani
    Zhang, Haibi
    Li, Liu
    Cheng, Haibo
    PHARMACEUTICAL BIOLOGY, 2017, 55 (01) : 937 - 945
  • [49] THE DEVELOPMENT AND VALIDATION OF A LC-MS/MS METHOD FOR THE DETERMINATION OF LUMEFANTRINE AND DESBUTYL LUMEFANTRINE IN WHOLE BLOOD ON SAMPLING PAPER
    Smit, I.
    Castel, S.
    Norman, J.
    Smit, P.
    Wiesner, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 278 - 279
  • [50] Development and validation of an LC-MS/MS method for relevant drugs in epilepsy patients using dried blood spots
    Moller, Ines
    Held, Kathrin
    Klimpel, Dennis
    Nadulski, Thomas
    Dufaux, Bertin
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (09)